Mesembrine

Mesembrine
Names
IUPAC name
(3aS,7aS)-3a-(3,4-Dimethoxyphenyl)-1-methyl-2,3,4,5,7,7a-hexahydroindol-6-one
Identifiers
CAS Number
  • 468-53-1 checkY
3D model (JSmol)
  • Interactive image
ChemSpider
  • 349381 ☒N
PubChem CID
  • 394162
UNII
  • P5X28MLQ1Z checkY
CompTox Dashboard (EPA)
  • DTXSID50947774 Edit this at Wikidata
InChI
  • InChI=1S/C17H23NO3/c1-18-9-8-17(7-6-13(19)11-16(17)18)12-4-5-14(20-2)15(10-12)21-3/h4-5,10,16H,6-9,11H2,1-3H3/t16-,17-/m1/s1 checkY
    Key: DAHIQPJTGIHDGO-IAGOWNOFSA-N checkY
  • InChI=1/C17H23NO3/c1-18-9-8-17(7-6-13(19)11-16(17)18)12-4-5-14(20-2)15(10-12)21-3/h4-5,10,16H,6-9,11H2,1-3H3/t16-,17-/m1/s1
    Key: DAHIQPJTGIHDGO-IAGOWNOFBH
  • CN1CC[C@@]2([C@H]1CC(=O)CC2)C3=CC(=C(C=C3)OC)OC
Properties
Chemical formula
C17H23NO3
Molar mass 289.375 g·mol−1
log P 1.1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references
Chemical compound

Mesembrine is an alkaloid present in Sceletium tortuosum (kanna).[1] It has been shown to act as a serotonin reuptake inhibitor (Ki = 1.4 nM), and more recently, has also been found to behave as a weak inhibitor of the enzyme phosphodiesterase 4 (PDE4) (Ki = 7,800 nM).[2] In an in vitro study published in 2015, researchers concluded that "a high-mesembrine Sceletium extract" may exert anti-depressant effects by acting as a monoamine releasing agent."[3] As such, mesembrine likely plays a dominant role in the antidepressant effects of kanna.[4] The levorotatory isomer, (−)-mesembrine, is the natural form.[5]

Rat studies have evaluated effects of kanna extract, finding analgesic and antidepressant potential.[6] No adverse results were noted for a commercial extract up to 5000 mg/kg daily in rats.[7]

Mesembrine has also been identified in Mesembryanthemum cordifolium, Delosperma echinatum and Oscularia deltoides.[8]

Total synthesis

Mesembrine was first isolated and characterized by Bodendorf, et al. in 1957.[9] It is a tricyclic molecule and has two bridgehead chiral carbons between the five-membered ring and the six-membered ring (highlighted in green in the figure below). Because of its structure and bioactivity, mesembrine has been a target for total synthesis over the past 40 years. Over 40 total syntheses have been reported for mesembrine, most of which focused on different approaches and strategies for the construction of the bicyclic ring system and the quaternary carbon.

Structure of mesembrine

The first total synthesis of mesembrine was reported by Shamma, et al.[10] in 1965. This route has 21 steps, which was among the longest synthetic routes for mesembrine. Key steps involve the construction of the six-membered ketone ring by Diels-Alder reaction, α-allylation for synthesis of the quaternary carbon, and conjugate addition reaction for the final five-membered ring closure. The final product from this route is a racemic mixture of (+)- and (-)-mesembrine.

Shamma's route for total synthesis of (±)-mesembrine

In 1971, Yamada, et al.[11] reported the first asymmetric total synthesis of (+)-mesembrine. The quaternary carbon was introduced by asymmetric Robinson annulation reaction mediated by an L-proline derivative.

Yamada's asymmetric total synthesis of (±)-mesembrine

References

  1. ^ Smith, M. T.; Crouch, N. R.; Gericke, N.; Hirst, M. (March 1996). "Psychoactive constituents of the genus Sceletium N.E.Br. and other Mesembryanthemaceae: A Review". Journal of Ethnopharmacology. 50 (3): 119–130. doi:10.1016/0378-8741(95)01342-3. PMID 8691846.
  2. ^ Harvey, A. L.; Young, L. C.; Viljoen, A. M.; Gericke, N. P. (October 2011). "Pharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum and its principal alkaloids". Journal of Ethnopharmacology. 137 (3): 1124–1129. doi:10.1016/j.jep.2011.07.035. PMID 21798331.
  3. ^ Coetzee, D. D.; López, V.; Smith, C. (November 2015). "High-mesembrine Sceletium extract (Trimesemine™) is a monoamine releasing agent, rather than only a selective serotonin reuptake inhibitor". Journal of Ethnopharmacology. 177: 111–116. doi:10.1016/j.jep.2015.11.034. PMID 26615766.
  4. ^ Stafford, G. I.; Pedersen, M. E.; van Staden, J.; Jäger, A. K. (October 2008). "Review on plants with CNS-effects used in traditional South African medicine against mental diseases". Journal of Ethnopharmacology. 119 (3): 513–537. doi:10.1016/j.jep.2008.08.010. PMID 18775771.
  5. ^ Coggon, P.; Farrier, D.S.; Jeffs, P.W.; McPhail, A.T. (1970). "Absolute configuration of mesembrine and related alkaloids: X-ray analysis of 6-epimesembranol methiodide". J. Chem. Soc. B: 1267–1271. doi:10.1039/J29700001267.
  6. ^ Loria, M. J.; Ali, Z; Abe, N; Sufka, K. J.; Khan, I. A. (Aug 8, 2014). "Effects of Sceletium tortuosum in rats". J. Ethnopharmacol. 155 (1): 731–5. doi:10.1016/j.jep.2014.06.007. PMID 24930358.
  7. ^ Murbach, T. S.; Hirka, G; Szakonyiné, I. P.; Gericke, N; Endres, J. R. (Dec 2014). "A toxicological safety assessment of a standardized extract of Sceletium tortuosum (Zembrin(®)) in rats". Food Chem. Toxicol. 74: 190–9. doi:10.1016/j.fct.2014.09.017. PMID 25301237.
  8. ^ Smith, Michael T.; Field, Courtney R.; Crouch, Neil R.; Hirst, Manton (January 1998). "The Distribution of Mesembrine Alkaloids in Selected Taxa of the Mesembryanthemaceae and their Modification in the Sceletium Derived 'Kougoed'". Pharmaceutical Biology. 36 (3): 173–179. doi:10.1076/phbi.36.3.173.6350.
  9. ^ Bodendorf, K.; Krieger, W., Arch. Pharm. 1957, 290, 441
  10. ^ Shamma, M.; Rodriguez, H., Tetrahedron Lett. 1965, 6, 4847. doi:10.1016/S0040-4039(01)89046-8
  11. ^ Yamada, S; Otani, G. Tetrahedron Lett. 1971, 12, 1133.
  • v
  • t
  • e
DATTooltip Dopamine transporter
(DRIsTooltip Dopamine reuptake inhibitors)
NETTooltip Norepinephrine transporter
(NRIsTooltip Norepinephrine reuptake inhibitors)
SERTTooltip Serotonin transporter
(SRIsTooltip Serotonin reuptake inhibitors)
VMATsTooltip Vesicular monoamine transportersOthers
See also: Receptor/signaling modulators • Monoamine releasing agents • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins
  • v
  • t
  • e
PDE1
PDE2
PDE3
PDE4
PDE5
PDE7
PDE9
PDE10
PDE11
BC11-38
Non-selective
Unsorted
See also: Receptor/signaling modulators